Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BLISSGVS | NSE
-6.11
-2.27%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
262.68
270.00
270.00
256.25
Bliss GVS Pharma Limited develops manufactures and markets pharmaceutical formulations in India. It offers pharma products including capsules creams/gels/ointments dry powder for injections and oral suspensions effervescent tablets eye/ear drops injections liquid preparations lotions lozenges nasal solutions oral solids parenterals pessaries sachets soft gelatin capsules suppositories suspensions syrups tablets topical preparations and transdermal patches. The company provides other healthcare products such as balms creams lotions lozenges nasal inhalers over the counter products petroleum jellies powders roll-ons shampoos soaps solutions sprays syrups and vaginal washes. In addition it offers therapeutic products consisting of anti-bacterial anti-dandruff shampoo amino acid preparation iron tonic antitussive appetite stimulant anti-allergic body supplement anti-biotic anti-diabetic anti-diarrheal anti-emetic anti-fungal anti-haemorrhoidal anti-helmintic anti-infective anti-inflammatory anti-malarial anti-microbial anti-migraine anti-oxidant anti-protozoal ear wax solvent anti-pyretic anti-septic anti-spasmodic anti-ulcer and anti-ulcerant; and analgesic oral rehydration antacid anxiolytic appetizer cough syrup erectile dysfunction haematinic hand sanitizer health supplement insecticide laryngitis pharyngitis laxative lubricant mosquito repellant nasal decongestant nutritional supplement moisturizer prickly heat powder skin lightening lotion vaginal contraceptive vaginal hygiene and vitamin supplements as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai India.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
38.7%1 month
51.9%3 months
59.9%6 months
68.6%17.04
-
1.51
0.10
0.08
8.99
1.80
-
1.59B
27.66B
289.10M
0.38
14.97
39.90
15.10
8.50
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
29.50
Range1M
71.65
Range3M
120.34
Rel. volume
0.64
Price X volume
389.03M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 298.3 | 29.92B | 0.61% | 50.00 | 62.51% |
| Orchid Pharma Limited | ORCHPHARMA | Drug Manufacturers-Specialty & Generic | 566.85 | 28.86B | 0.01% | 59.92 | 11.56% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 169.01 | 26.50B | -3.17% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 372.35 | 26.31B | -3.39% | n/a | 10.48% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 91.42 | 23.56B | -2.15% | 12.29 | 0.42% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 41.72 | 23.05B | -2.27% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 368.55 | 23.00B | 3.38% | n/a | 2.49% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 181.1 | 22.33B | -3.22% | 69.03 | 68.84% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 477.5 | 20.69B | -4.24% | n/a | 107.90% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.34 | 19.01B | -3.48% | 42.22 | 60.54% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.99 | 24.85 | Cheaper |
| Ent. to Revenue | 1.80 | 11.40 | Cheaper |
| PE Ratio | 17.04 | 51.36 | Cheaper |
| Price to Book | 1.51 | 6.83 | Cheaper |
| Dividend Yield | 0.38 | 0.52 | Poor |
| Std. Deviation (3M) | 59.85 | 42.17 | Riskier |
| Debt to Equity | 0.10 | 0.35 | Cheaper |
| Debt to Assets | 0.08 | 0.17 | Cheaper |
| Market Cap | 27.66B | 290.82B | Emerging |